AtriCure Inc (ATRC)
23.14
+0.51
(+2.25%)
USD |
NASDAQ |
May 17, 16:00
23.07
-0.07
(-0.30%)
After-Hours: 20:00
AtriCure Research and Development Expense (Quarterly): 19.84M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.84M |
| December 31, 2023 | 20.80M |
| September 30, 2023 | 20.35M |
| June 30, 2023 | 17.44M |
| March 31, 2023 | 15.33M |
| December 31, 2022 | 13.75M |
| September 30, 2022 | 15.17M |
| June 30, 2022 | 14.79M |
| March 31, 2022 | 13.63M |
| December 31, 2021 | 13.81M |
| September 30, 2021 | 11.28M |
| June 30, 2021 | 12.20M |
| March 31, 2021 | 11.22M |
| December 31, 2020 | 10.87M |
| September 30, 2020 | 10.58M |
| June 30, 2020 | 10.04M |
| March 31, 2020 | 11.59M |
| December 31, 2019 | 13.10M |
| September 30, 2019 | 10.15M |
| June 30, 2019 | 9.804M |
| March 31, 2019 | 8.176M |
| December 31, 2018 | 8.455M |
| September 30, 2018 | 8.556M |
| June 30, 2018 | 8.655M |
| March 31, 2018 | 9.057M |
| Date | Value |
|---|---|
| December 31, 2017 | 7.721M |
| September 30, 2017 | 7.966M |
| June 30, 2017 | 8.907M |
| March 31, 2017 | 9.55M |
| December 31, 2016 | 9.866M |
| September 30, 2016 | 8.271M |
| June 30, 2016 | 9.124M |
| March 31, 2016 | 8.563M |
| December 31, 2015 | 7.767M |
| September 30, 2015 | 6.504M |
| June 30, 2015 | 5.862M |
| March 31, 2015 | 5.609M |
| December 31, 2014 | 4.997M |
| September 30, 2014 | 5.033M |
| June 30, 2014 | 4.569M |
| March 31, 2014 | 4.001M |
| December 31, 2013 | 3.648M |
| September 30, 2013 | 3.237M |
| June 30, 2013 | 3.049M |
| March 31, 2013 | 3.506M |
| December 31, 2012 | 2.967M |
| September 30, 2012 | 2.905M |
| June 30, 2012 | 2.885M |
| March 31, 2012 | 3.389M |
| December 31, 2011 | 2.964M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
9.804M
Minimum
Jun 2019
20.80M
Maximum
Dec 2023
13.79M
Average
13.36M
Median
Research and Development Expense (Quarterly) Benchmarks
| Alphatec Holdings Inc | 18.01M |
| Intuitive Surgical Inc | 284.50M |
| LeMaitre Vascular Inc | 4.092M |
| iRhythm Technologies Inc | 16.99M |
| RxSight Inc | 8.031M |